实时全球研报
2Q26 miss with slipping food earnings
研报英文原文证据摘录
Not for redistribution without written consent of Morgan Stanley
M
Update
August 11, 2026 11:43 AM GMT
Morgan Stanley & Co. International plc, Seoul Branch+
CJ Cheil Jedang Corp | Asia Pacific
Kelly H Kim, CFA
Equity Analyst
2Q26 miss with slipping food
earnings
Jenna Lee
Equity Analyst
What’s Changed
CJ Cheil Jedang Corp (097950.KS)
From
To
Price Target
W230,000
W210,000
CJ Cheil Jedang Corp (097950.KS, 097950 KP)
AlphaSignals Earnings Reaction
S. Korea Consumer | S. Korea
Unchanged
Modest shortfall
Modest revision lower
Impact to our thesis
Financial results versus consensus
Direction of next 12-month
consensus EPS
Source: Company data, Morgan Stanley Research
CJCJ posted 2Q26 core-OP of W162bn, down 18% YoY. Albeit
healthy sales growth in key products and FX benefits, rising
marketing and logistics costs dragged food margins. Bio earnings
rebounded quickly QoQ on ASP hikes with fast margin recovery.
We cut our price target by 9% to W210,000.
Key Takeaways
Food sales rose 6% YoY on stable domestic proceed food sales (+4% YoY) and
improving overseas sales growth (+10% YoY), aided by favorable FX trends.
However, food OPM contracted to 2.5% (vs. 3.4% in 2Q25), reflecting higher
marketing investment in overseas markets and a surge in logistics costs.
Bio OP was W91bn (6.7% OPM), a sharp rise from W6bn in 1Q26, owing to the
commodity upcycle and higher production volumes.
We lower our OPM assumption for foods, reflecting 1) higher marketing costs as
the company focuses on overseas sales and 2) limited pricing power.
Stock Rating
Industry View
Price target
Up/downside to price target (%)
Shr price, close (Aug 10, 2026)
52-Week Range
Sh out, dil, curr (mn)
Mkt cap, curr (bn)
EV, curr (bn)
Avg daily trading value (bn)
Equal-weight
In-Line
W210,000
2
W205,500
W254,000-172,600
15
W3,094
W14,659
W15
Fiscal Year Ending
12/25 12/26e 12/27e 12/28e
EPS (W)**
Prior EPS (W)**
EPS (W)§
Revenue, net (W bn)
EBITDA (W bn)
ModelWare net inc (W
bn)
P/E
P/BV
RNOA (%)
ROE (%)
EV/EBITDA
Div yld (%)
FCF yld ratio (%)
Leverage (EOP) (%)
12,064
23,353
29,452
2,950
182
23,918
27,282
24,286
29,734
2,912
360
31,204
34,276
28,943
31,031
3,162
470
35,520
38,493
36,453
32,307
3,299
535
17.2
…
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器